首页|无定型固体分散体相态表征研究进展

无定型固体分散体相态表征研究进展

扫码查看
固体分散体技术是改善难溶性药物溶出度和生物利用度的先进技术。抑制无定型固体分散体(ASD)活性药物成分的重结晶和非晶相分离是保证产品稳定性的关键手段,因此ASD相态的表征至关重要。本文从相分离的原理出发,对各种表征技术的优缺点与适用性进行分析与总结,为ASD的表征及稳定性研究提供有效参考。
Research progress on characterization of phase separation of amorphous solid dispersion
Solid dispersion technology is an advanced technology to improve the solubility and bioavailability of poorly soluble drugs.Inhibition of the recrystallization and amorphous phase separation of amorphous solid dispersion (ASD) active pharmaceutical ingredients are important to ensure product stability,so the characterization of ASD phase separation is essential.Based on the principle of phase separation,this paper analyzed and summarized the advantages,disadvantages and applicability of the various characterization techniques,in order to provide an efficient reference for the characterization and stability study of ASD.

Amorphous solid dispersionPhase separationCharacterization techniquesStabilityRecrystallizationRegulatory requirements

朱玲、王慧洁、王欢、李瑶、赵媛媛、周浩

展开 >

正大天晴药业集团股份有限公司,南京 211100

无定型固体分散体 相分离 表征技术 稳定性 重结晶 监管要求

2024

中国药师
国家药品监督管理局高级研修学院,武汉医药(集团)股份有限公司

中国药师

CSTPCD
影响因子:0.944
ISSN:1008-049X
年,卷(期):2024.28(10)